Delivery Order SPE2DB20D1100-SPE2DB24FA7X8
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,024.40, is for the supply of 4,568,093,049 units of Remicade 100 mg vials. The award has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $23,954.18 and covers the delivery of Remicade 100 mg vials. It is a firm fixed-price contract with an ultimate completion date of April 16, 2025. The contract is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Remicade 100 mg vials, a prescription medication, with a ceiling value of $2,294.25 and a performance period ending on June 10, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $25,767.48 award is for the supply of 100 mg vials of the pharmaceutical drug Remicade. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of REMICADE 100 MG VIALS. The contract has a ceiling value of $35,458.10 and is a firm fixed price delivery order that runs through August 8, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Remicade (infliximab) 100 mg vials. The contract has a ceiling value of $5,582.95 and a period of performance through July 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which has a...
- The Defense Logistics Agency awarded a delivery order valued at $12,029.28 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 4, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The contract carries no set-aside designation, reflecting open competition among qualified pharmaceutical distributors. This delivery order is issued under...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 100 mg vials of the drug Remicade. The delivery order has a ceiling value of $24,400.81 and a completion date of July 9, 2025. The contract is a firm-fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,327.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 100 mg Remicade vials. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide....
- This is a delivery order worth $12,739.86 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp under an Indefinite Delivery Contract (IDC) for the supply of 100mg vials of the biologic drug Remicade. The ultimate completion date for this delivery order is September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies to support military treatment facilities and federal healthcare programs. The contract does not have...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA7X8Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is for the supply of Remicade 100 mg vials, a specialty brand name medication. The delivery order has a ceiling value of $44,623.83 and a period of performance through March 19, 2024. AmerisourceBergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense military treatment facilities worldwide. The contract award does not include any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.6k | 3/18/24 |